维普中文期刊产品整合服务
210篇 您的检索式:作者名="PAI S C"
    题名 作者 年代 出处 被引量
1Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial显示文摘AIM: To investigate efficacy and safety of cetuximab combined with two chemotherapy regimens in patients with unresectable metastatic colorectal cancer (mCRC). METHODS: Randomized patients received cetuximab with 5-fluorouracil (5-FU), folinic acid (FA) and oxaliplatin (FOLFOX) 6 (arm A, n = 74) or 5-FU, FA and irinotecan (FOLFIRI) (arm B, n = 77). KRAS mutation status was determined retrospectively in a subset of tumors (n = 117). RESULTS: No significant difference was found between treatment arms A and B in the progression-free survival (PFS) rate at 9 mo, 45% vs 34%; median PFS, 8.6 mo vs 8.3 mo [hazard ratio (HR) = 1.06]; overall response rate (ORR) 43% vs 45% [odds ratio (OR) = 0.93] and median overall survival (OS), 17.4 mo vs 18.9 mo (HR = 0.98). Patients with KRAS wild-type tumors demonstrated improved PFS (HR = 0.55, P = 0.0051), OS, (HR = 0.62, P = 0.0296) and ORR (53% vs 36%) and in arm A, improved PFS (HR = 0.49, P = 0.0196), OS (HR = 0.48, P = 0.0201) and ORR (56%vs 30%), compared with patients with KRAS mutated tumors. In arm B no significant differences were found in efficacy by KRAS mutation status. Treatment in arms A and B was generally well tolerated. CONCLUSION: This study confirms that combinations of cetuximab with FOLFOX6 or FOLFIRI are effective and significantly improve clinical outcome in KRAS wild-type compared with KRAS mutated mCRC.Janja Ocvirk Thomas Brodowicz Fritz Wrba Tudor E Ciuleanu Galina Kurteva Semir Beslija Ivan Koza Zsuzsanna Pápai Diethelm Messinger Ugur Yilmaz Zsolt Faluhelyi Suayib Yalcin Demetris Papamichael Miklós Wenczl Zrinka Mrsic-Krmpotic Einat Shacham-Shmueli Damir Vrbanec Regina Esser Werner Scheithauer Christoph C Zie-linski 2010World Journal of Gastroenterology2010,16,25:17
2Improving hierarchical cluster analysis: a new method with outlier detection and automatic clustering显示文摘ALMEIDA J A S BARBOSA L M S PAIS A A C C 2007Chemometrics and Intelligent Labora- tory Systems2007,87,2:1
3Iberian Universities: a Characterisation from ESI Ranldngs显示文摘Cova T F G G Pais A A C C Formosinho S O J 2013Scientomet- tics2013,94,3:1
4Microstructure and mechanical properties of Si and Sb added AZ91 magnesium alloy显示文摘SRINIVASAN A PILLAI U T S PAI B C 2005Metallurgical and Materials Transactions A2005,36,8:1
5Effects acidity and molybdate concentration on the kinetics of the formation of the phosphoantimonylmolybdenum blue complex显示文摘PAI S C YANG C C RILEY J P 1990Analytica Chimica1990,229,:1
6Microstructure and mechanical properties of Si and Sb added AZ91 magnesium alloy 显示文摘SRINIVASAN A PILLAI U T S PAI B C 2005Metallurgical and Materials Transactions A2005,36,8:1
7Radiofrequency-assisted hepatic resection显示文摘Pai M Kyriakides C Mikhail S 2011Ann Surg Oncol2011,18,12:1
8critical roles for transcription factor GATA-3 in thymocyte development显示文摘Pai S Y Truitt M L Ting C N 0,,:1
9显示文摘Hwang T L Pai Y M Liu C S 1980J Am Chem Soc1980,102,25:1
10Potential applications of aerobic denitrifiying bacteria as bio-agents in waste water treatment显示文摘Pai S L Chong N M Chen C H 1999Bioresource Technology1999,68,2:1
11J Catal显示文摘Kumar S B Mirajkar S P Pais G C G Kumar P Kumar R 1995156:1631995,156,:1
12Potential applications of aerobic denitrifiying bacteria as bioagents In waste water treatment显示文摘Pai S L Chong N M Chen C H 0,,02:1
13Improving hierarchical cluster analysis: A new method with outlier detection and automatic clustering显示文摘ALMEIDA J A S BARBOSA L M S PAIS A A C C 2007Chemometrics and Intelligent Laboratory Systems2007,87,:1
14Optimization of heat treatment parameters in ZA84 magnesium alloy 显示文摘BALASUBRAMANI N PILLAI U T S PAI B C 2008J Alloys Comp2008,457,12:1
15Safety and antitumor activity of recombinant soluble Apo2 ligand显示文摘Ashkenazi A Pai R C Fong S 1999Journal of Clinical Investigation1999,104,:1
16Optimization of heat treatment parameters in ZA84 magnesium alloy显示文摘BALASUBRAMANI N PILLAI U T S PAI B C 2008J Alloys Compd2008,457,:1
17Homogeneneous Catalytic Hydroformylation of Vinylarenes:A Selective Rhodium Diphosphine Catalyst System for Highter Branched/Linear Product Ratios显示文摘CHAN A S C PAI C C YANG T K CHEN S-M 1995J Chem Soc Chem Commun1995,,:1
18Education and cognitive decline in Parkinson's disease: a study of 102 patients显示文摘Pai M C Chart S H 2001Acta Neurol Scand2001,103,4:1
19Exchange of water masses between the East China Sea and the Kuroshio off northeastern Taiwan 显示文摘CHEN C T A RUO R PAI S C 1995Continental Shelf Research1995,15,1:1
20Critical roles for transcrip- tion factor GATA in thymoeyte development 显示文摘Pai S Y Truitt M L Ting C N 2003Immunity2003,19,6:1
返回顶部 每页显示:
共11页 首页 上一页 第1页 下一页 末页 /11 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费